X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19) 19
index medicus (19) 19
pharmacology & pharmacy (19) 19
europe (13) 13
pharmacology (12) 12
austria (10) 10
drugs (10) 10
reimbursement (9) 9
health care sciences & services (8) 8
analysis (7) 7
demand-side measures (7) 7
statins (7) 7
generics (6) 6
health care economics and organizations (6) 6
health policy & services (6) 6
impact (6) 6
adult (5) 5
dabigatran (5) 5
drugs, generic - economics (5) 5
female (5) 5
hypertension (5) 5
internal medicine (5) 5
male (5) 5
medicine (5) 5
middle aged (5) 5
pharmaceuticals (5) 5
proton pump inhibitors (5) 5
care (4) 4
diabetes (4) 4
drugs, generic - therapeutic use (4) 4
health policy (4) 4
management (4) 4
medicin och hälsovetenskap (4) 4
medicines (4) 4
public, environmental & occupational health (4) 4
rare diseases (4) 4
research (4) 4
usage (4) 4
adaptive pathways (3) 3
aged (3) 3
angiotensin ii type 1 receptor blockers - therapeutic use (3) 3
atrial-fibrillation (3) 3
austria - epidemiology (3) 3
cancer drugs (3) 3
care and treatment (3) 3
cohort studies (3) 3
cost (3) 3
cost-effectiveness (3) 3
countries (3) 3
critical drug evaluation (3) 3
diabetes mellitus - drug therapy (3) 3
disease (3) 3
dosage and administration (3) 3
drug costs (3) 3
drug utilization (3) 3
efficiency (3) 3
enhance prescribing efficiency (3) 3
generic drugs (3) 3
health technology assessment (3) 3
health technology-assessment (3) 3
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (3) 3
hypertension - drug therapy (3) 3
hypolipidemic agents - economics (3) 3
initiatives (3) 3
losartan (3) 3
managed entry agreements (3) 3
marketing authorization (3) 3
medical and health sciences (3) 3
medicine, general & internal (3) 3
original research (3) 3
patients (3) 3
payers (3) 3
practice patterns, physicians' - trends (3) 3
prevalence (3) 3
quality (3) 3
research article (3) 3
review (3) 3
rheumatoid-arthritis (3) 3
risk (3) 3
technology assessment (3) 3
trials (3) 3
access (2) 2
aged, 80 and over (2) 2
ambulatory care - economics (2) 2
ambulatory care - trends (2) 2
angiotensin ii type 1 receptor blockers - administration & dosage (2) 2
angiotensin ii type 1 receptor blockers - economics (2) 2
angiotensin prescribing efficiency (2) 2
angiotensin receptor blockers (2) 2
angiotensin-converting enzyme inhibitors - therapeutic use (2) 2
antihypertensive agents - economics (2) 2
antipsychotic agents (2) 2
atypical antipsychotic-drugs (2) 2
basic medicine (2) 2
cancer (2) 2
cardiovascular agents (2) 2
case-history (2) 2
comparative effectiveness research (2) 2
converting enzyme-inhibitors (2) 2
coronary-heart-disease (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Health Policy, ISSN 0168-8510, 2017, Volume 123, Issue 2, pp. 140 - 151
Highlights • OMPs are often cost-ineffective and their value is characterised by greater uncertainty. • New EU/national HTA programmes for (ultra-)OMPs aim to... 
Internal Medicine | Rare diseases | Uncertainty | Europe | Technology assessment | England | Scotland | Value of life | QUALITY | METHODOLOGICAL FRAMEWORK | CONTEXT | ISSUES | DECISIONS | NEED | HEALTH CARE SCIENCES & SERVICES | HEALTH POLICY & SERVICES | PATIENT | DRUG POLICIES | LIFE | Orphans | Literature reviews | Medical technology | Challenges | Criteria | Stakeholders | Clinical practice | Process evaluation | Quality adjusted life years
Journal Article
Frontiers in Pharmacology, ISSN 1663-9812, 2013, Volume 4, p. 39
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2015, Volume 10, Issue 11, p. e0143429
Background Faster fibrosis progression and hepatic steatosis are hallmarks of HIV/HCV coinfection. A single nucleotide polymorphism (SNP) of the PNPLA3-gene is... 
TRANSIENT ELASTOGRAPHY | RISK-FACTORS | MULTIDISCIPLINARY SCIENCES | PEGYLATED INTERFERON | VIRUS/HEPATITIS-C-VIRUS | HCV GENOTYPE | ANTIRETROVIRAL THERAPY | VIRAL-HEPATITIS | VIROLOGICAL RESPONSE | INTERFERON PLUS RIBAVIRIN | HIV-INFECTED PATIENTS | Liver - pathology | Hypertension, Portal - physiopathology | Prevalence | Age Factors | Humans | Middle Aged | Male | Risk | Hepatitis C, Chronic - complications | Coinfection - complications | Interleukins - genetics | Adult | Female | Liver Cirrhosis - genetics | Cross-Sectional Studies | Membrane Proteins - genetics | Fatty Liver - physiopathology | HIV Infections - genetics | Genotype | Treatment Outcome | Coinfection - virology | Pressure | Disease Progression | Biopsy | Alleles | Fibrosis | HIV Infections - complications | Polymorphism, Single Nucleotide | Liver Cirrhosis - physiopathology | Hepatitis C, Chronic - genetics | Elasticity Imaging Techniques | Cohort Studies | Lipase - genetics | Complications and side effects | Usage | Care and treatment | Comorbidity | Development and progression | Single nucleotide polymorphisms | Research | Liver cirrhosis | HIV infection | Risk factors | Therapy | Pathogenesis | Liver | Infections | Single-nucleotide polymorphism | Gene polymorphism | Genotype & phenotype | Hepatitis | Fatty liver | Immunology | Acquired immune deficiency syndrome--AIDS | Hepatology | Human immunodeficiency virus--HIV | Gastroenterology | Genotypes | Hypertension | Liver diseases | Internal medicine | Dermatology | Patients | Steatosis | Medicine | Infectious diseases | Body mass | Polymorphism | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Journal Article
Journal Article
BMC Medicine, ISSN 1741-7015, 06/2014, Volume 12, Issue 1, pp. 98 - 98
Journal Article
Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, 01/2016, Volume 25, Issue 1, pp. 90 - 99
Purpose Double medication is defined as the unintended overlapping prescription of two identical substances with the same route of administration by two... 
hyperlipidemia | drug utilization | duplicate prescription | anatomical therapeutic chemical (ATC) classification system | diabetes mellitus | hypertension | pharmacoepidemiology | Hypertension | Pharmacoepidemiology | Hyperlipidemia | Diabetes mellitus | Drug utilization | Anatomical therapeutic chemical (ATC) classification system | Duplicate prescription | ADHERENCE | INTERVENTIONS | NONADHERENCE | PHARMACOLOGY & PHARMACY | PATIENT | HEALTH-CARE | Hypoglycemic Agents - therapeutic use | Prevalence | Hypoglycemic Agents - economics | Humans | Hyperlipidemias - drug therapy | Diabetes Mellitus - drug therapy | Inappropriate Prescribing - statistics & numerical data | Antihypertensive Agents - administration & dosage | Austria - epidemiology | Hypertension - drug therapy | Inappropriate Prescribing - prevention & control | Antihypertensive Agents - therapeutic use | Hyperlipidemias - epidemiology | Drug Prescriptions - statistics & numerical data | Hypolipidemic Agents - economics | Drug Costs - statistics & numerical data | Hypoglycemic Agents - administration & dosage | Diabetes Mellitus - epidemiology | Hypolipidemic Agents - administration & dosage | Patient Safety | Hypolipidemic Agents - therapeutic use | Hypertension - epidemiology | Antihypertensive Agents - economics | Cohort Studies | Hypoglycemic agents | Analysis | Anticholesteremic agents | Prevalence studies (Epidemiology) | Medical care, Cost of | Pharmacology | Internal medicine | Hypoglycemia
Journal Article
Frontiers in Pharmacology, ISSN 1663-9812, 07/2016, Volume 7, p. 197
Journal Article
Expert Review of Clinical Pharmacology, ISSN 1751-2433, 01/2014, Volume 8, Issue 1, pp. 77 - 94
Journal Article